SCHEMBL28043774

SCHEMBL28043774

Cc1cc(C)cc(-c2cc(NCCc3ccc(F)cc3)nc(N)n2)c1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 9/20 0.49
TLR8 Q9NR97 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTR7 P34969 2/20 0.45
ADRA1D P25100 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA1A P35348 1/20 0.45
ADRA1B P35368 1/20 0.45
HTR6 P50406 1/20 0.45
MAP4K4 O95819 1/20 0.43
PTGDR Q13258 2/20 0.42
CYP3A4 P08684 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
ADORA2A P29274 1/20 0.40
ACP1 P24666 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28151182 0.91 HRH4 (0.52) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28043933 0.89 HRH4 (0.50) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28043806 0.88 ALDH1A1 (0.52) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28043771 0.88 HRH4 (0.62) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28043714 0.86 HRH4 (0.50) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28267214 0.86 PTGDR (0.57) PTGDR
SCHEMBL28152055 0.85 PTGDR (0.48) HRH4TLR8ALDH1A1SMN1; SMN2HTR7
SCHEMBL28152277 0.84 HRH4 (0.48) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28151068 0.84 PTGDR (0.58) HRH4TLR8ALDH1A1SMN1; SMN2PTGDR
SCHEMBL28151149 0.83 HRH4 (0.64) HRH4TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN claimed
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed
CN-106794181-A MTH1 inhibitors for the treatment of inflammatory and autoimmune conditions 托马斯·黑勒戴药物研究基金会 2017-05-31 CN disclosed
CN-105143206-A Pyrimidine-2,4-diamine derivatives for treatment of cancer THOMAS HELLEDAYS STIFTELSE F R MEDICINSK FORSKNING 2015-12-09 CN disclosed